OctoPlus Grants SurModics Access to Two Biodegradable Polymer Families for Medical Device Applications
Biodegradable polymers have the ability to be combined with one or more drugs and applied to a medical device, yet are naturally degraded by the body over time. The two polymer families covered under this agreement are PolyActive(tm) and OctoDEX(tm), which are currently under pre-clinical and clinical evaluation by OctoPlus for use as pharmaceutical drug delivery products.
PolyActive(tm) is a biodegradable multiblock polymeric drug delivery system based on two well-known polymers. Its biodegradability, extensive safety record and tunable release properties make it an excellent choice for the controlled release of proteins and hydrophobic small molecule drugs. In particular, PolyActive(tm) has been used in thousands of patients as part of two FDA approved products, and has an existing FDA Master File.
OctoDEX(tm) is a delivery system for the controlled release of proteins and large particles such as liposomes and antigens and is based on cross-linked dextran microspheres. OctoPlus recently reported successful completion of Phase I studies for a sustained release formulation of human growth hormone based on OctoDEX(tm).
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.